How to Save Money on NovoEight in 2026: Coupons, Discounts, and Patient Assistance

NovoEight (turoctocog alfa) is one of the most expensive medications in the world. As a specialty biologic factor VIII replacement therapy for hemophilia A, annual treatment costs can range from tens of thousands to hundreds of thousands of dollars, depending on body weight and dosing frequency. For patients and families managing this condition, every dollar of savings matters.

The good news: Novo Nordisk has built a comprehensive support infrastructure through their NovoCare program. Here's a complete breakdown of every savings option available for NovoEight in 2026.

How Much Does NovoEight Cost Without Insurance?

NovoEight's cost is not like typical medications that have a simple per-pill price. Because dosing is weight-based and given in international units (IU), the total cost depends on your weight, severity of hemophilia, and whether you are on prophylaxis or only on-demand treatment.

As a branded specialty biologic, NovoEight's wholesale acquisition cost is in the range that makes full out-of-pocket payment impractical for nearly all patients. This is why insurance coverage, manufacturer savings programs, and patient assistance are essential — not optional — for most NovoEight users.

Option 1: NovoCare Copay Savings Card (Commercially Insured Patients)

If you have commercial (private) insurance that covers NovoEight, Novo Nordisk's copay savings card can reduce your out-of-pocket cost to as little as $0 per fill, subject to a maximum savings of $12,000 per calendar year.

Important eligibility rules:

You must have a valid prescription for NovoEight covered by your commercial insurance plan

Government program patients (Medicare, Medicaid, TRICARE, VA, etc.) are NOT eligible

Full cash-paying patients (no insurance) are excluded from this specific program

Must be redeemed at a participating retail or specialty pharmacy

To enroll, call NovoCare at 1-844-668-6732 or visit novoeight.com. The card is typically activated when you first fill your prescription.

Option 2: NovoSecure Patient Assistance Program (Uninsured or Underinsured)

Uninsured or underinsured patients who meet income and eligibility criteria may qualify to receive NovoEight at no cost through the NovoSecure Patient Assistance Program (PAP). The PAP is administered by Novo Nordisk and requires:

US citizenship or legal residency

No insurance coverage (or insurance that does not cover NovoEight)

Income guidelines set by Novo Nordisk (subject to change — confirm current guidelines when applying)

Valid prescription from a licensed healthcare provider for an FDA-approved indication

To apply: Fax your completed application to 1-866-488-6576 or ask NovoCare (1-844-668-6732) to initiate the process on your behalf.

Option 3: JumpStart Program (Insurance Coverage Gap — Starting Therapy)

If you've been prescribed NovoEight and your insurance hasn't yet approved coverage, the JumpStart Program provides a limited free supply of medication to bridge the gap while your insurance processes your prior authorization. This prevents treatment interruption during the approval wait period.

Option 4: Interim Program (Staying on Therapy During Coverage Gaps)

For patients already on NovoEight who experience a lapse in commercial insurance coverage — such as between jobs or during a coverage transition — the Interim Program provides continued medication supply to prevent a dangerous gap in therapy. Contact NovoCare for eligibility and enrollment.

Option 5: Medicaid and State Children's Health Insurance Programs (CHIP)

Medicaid typically covers hemophilia factor products including NovoEight, but formulary placement and copay requirements vary by state. Many states have Special Needs Plans or specific hemophilia coverage carve-outs. Contact your state's Medicaid office or your HTC's social worker to confirm coverage and maximize your benefits.

Option 6: Federally Funded HTC Programs

Many Hemophilia Treatment Centers receive federal funding from the CDC's Division of Blood Disorders. Some HTC programs may have access to discounted or supplemental factor product for qualifying patients. Ask your HTC social worker specifically about any available factor assistance funding.

How to Get Started: One Call Gets It All

Start with a single call to NovoCare: 1-844-668-6732. NovoCare specialists can verify your eligibility for all available programs in one conversation and help you enroll. If you're also having trouble locating your specific vial strength at a pharmacy, medfinder can check pharmacies near you to find which ones currently have NovoEight in stock.

If you're also struggling with access to NovoEight at your pharmacy, read: Why Is NovoEight So Hard to Find? [Explained for 2026].